Biography of Robert Davis | |
|
Mr. Robert M. Davis is an Independent Director at Duke Energy Corp., a President at Merck & Co., Inc. and a Chairman at Gambro AB. He is on the Board of Directors at Duke Energy Corp., AdvaMedDx, Project HOPE-The-People-To-People HealthFoundation, Inc. and Rush University Medical Center. Mr. Davis was previously employed as a Chief Financial Officer & Vice President by Baxter Healthcare Corp., a VP & President-Medical Products Business by Baxter International, Inc., and a Director-Corporate Financial Planning by Eli Lilly & Co. He also served on the board at C. R. Bard, Inc. (New Jersey). He received his undergraduate degree from Miami University, a graduate degree from Northwestern University School of Law and an MBA from Kellogg School of Management.
|
Current positions of Robert Davis | |
|
Name | Title |
Since |
Merck & Co., Inc. (Pharmaceuticals) |
Chairman, President & Chief Executive Officer |
- | Duke Energy Corporation (Electric Utilities) |
Independent Director |
2018 | Gambro AB |
Chairman |
- | Catalyst, Inc. |
Director |
- | Project HOPE-The-People-To-People HealthFoundation, Inc. |
Director |
- | Rush University Medical Center |
Trustee |
- | AdvaMedDx |
Director |
- | MSD Pharma (Singapore) Pte Ltd. |
President, Chief Executive Officer & Director |
2021 |
|
Robert Davis : Personal Network | |
|
Name | Linked companies |
Kathy Warden | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. Catalyst, Inc. |
Patricia Russo | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Inge Thulin | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Thomas Henry Glocer | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Pamela J. Craig | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Risa J. Lavizzo-Mourey | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Peter C. Wendell | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Paul B. Rothman | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Christine E. Seidman | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
Stephen L. Mayo | Merck & Co., Inc. MSD Pharma (Singapore) Pte Ltd. |
|
© 2023 People and Ownership :
|
Robert Davis : Connections | |
|
|
Latest news about Robert Davis | |
|
05/23 | Transcript : Merck & Co., Inc. - Shareholder/Analyst Call | CI |
05/04 | Transcript : Integra LifeSciences Holdings Corporation - Analyst/Investor Day | CI |
04/27 | Drugmakers scout for deals, ramp up research spending | RE |
04/27 | Drugmakers scout for deals, ramp up research spending | RE |
04/27 | Transcript : Merck & Co., Inc., Q1 2023 Earnings Call, Apr 27, 2023 | CI |
04/17 | Merck & Co., Inc., Prometheus Biosciences, Inc. - M&A Call | CI |
04/17 | Merck Buying Prometheus Biosciences for $10.8 Billion to Enhance Immunology Portfolio | MT |
|
|